Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 2
Submit an article Journal homepage
425
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

Shelf-life extension of azacitidine: waste and cost reduction in the treatment of myelodysplastic syndromes

Hany R. GuirguisHematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada
,
Lauren F. CharbonneauDepartment of Pharmacy, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada
,
Ivan TyonoDepartment of Pharmacy, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada
,
Richard A. WellsHematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada
,
Matthew C. CheungHematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada
&
Rena BucksteinHematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, CanadaCorrespondence[email protected]
Pages 542-544 | Received 12 Feb 2014, Accepted 18 May 2014, Published online: 17 Jul 2014

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jonathan Feld, Douglas Tremblay, Shyamala C. Navada & Lewis R. Silverman. (2023) Ascertaining QUAZARs: slow-motion and light-speed development of oral azacitidine and decitabine. Leukemia & Lymphoma 64:3, pages 525-539.
Read now

Articles from other publishers (1)

Kristin M. Sheffield, Julie Kay Beyrer, Ian A. Watson, Kathleen Stafford, Bradley J. Mills & Amine Ale-Ali. (2017) Minimization of olaratumab drug waste using real-world data. American Journal of Health-System Pharmacy 74:11, pages 832-842.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.